IBM today announced watsonx AI Labs, a new, developer-first innovation hub in New York City, designed to supercharge AI builders and accelerate AI adoption at scale. watsonx AI Labs connects IBM's enterprise resources and expertise with the next generation of AI developers in order to build breakthrough AI applications for business.
IBM and Roche used their collective innovation power and have developed an AI-enabled solution to ease the daily diabetes management: Roche’s Accu-Chek® SmartGuide Predict app. This solution underpins the importance of cross-industry collaboration and teamwork to support people with diabetes in their daily lives and the provision of healthcare.
Deutsche Bank and IBM today announced a continuation of their partnership in the form of a strategic agreement that grants Deutsche Bank further access to IBM's comprehensive suite of software solutions.
Today, the University of Tokyo (UTokyo) and IBM announced plans to deploy the latest 156-qubit IBM Heron* quantum processing unit (QPU), which will be operational in the IBM Quantum System One administered by UTokyo for the members of the Quantum Innovation Initiative (QII) Consortium. The IBM Heron QPU, which features a tunable-coupler architecture, delivers a significantly higher performance than the processor previously installed in 2023.
Finanz Informatik (FI) – the central IT service provider and digitalization partner of the Sparkassen-Finanzgruppe – and IBM have extended their successful collaboration with the signing of a new contract.
IBM Unveils watsonx AI Labs: The Ultimate Accelerator for AI Builders, Startups and Enterprises in New York City
IBM and Roche Co-Created an Innovative Solution to Support People with Diabetes in their Daily Lives with AI-Enabled Glucose Predictions
